Carl-Magnus Wahlgren

Carl-Magnus Wahlgren

Auto-generated profile, based on publicly available information

Carl-Magnus Wahlgren

Department of Molecular Medicine and Surgery, Vascular Surgery Karolinska Institutet Stockholm Sweden

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2014 in Circulation
Verified
Journal Article
Closed access
KSKarl Sörelius
Karl Sörelius
KMKevin Mani
Kevin Mani
MBMartin Björck
Martin Björck
PSPetr Sedivy
Petr Sedivy
CWCarl-Magnus Wahlgren
Carl-Magnus Wahlgren
AWAnders Wanhainen
Anders Wanhainen
Background—: Mycotic aortic aneurysm (MAA) is a rare and life-threatening disease. The aim of this European multicenter collaboration was to study the durability of endovascular aortic repair (EVAR) of MAA, by assessing late infection–related complications and long-term survival. Methods and Results—: All EVAR treated MAAs, between 1999 and 2013 at 16 European centers, were retrospectively reviewed. One hundred twenty-three patients with 130 MAAs were identified. Mean age was 69 years (range 39–86), 87 (71%) were men, 58 (47%) had immunodeficiency, and 47 (38%) presented with rupture. Anatomic locations were ascending/arch (n=4), descending (n=34), paravisceral (n=15), infrarenal aorta (n=63), and multiple (n=7). Treatments were thoracic EVAR (n=43), fenestrated/branched EVAR (n=9), and infrarenal EVAR (n=71). Antibiotic was administered for mean 30 weeks. Mean follow-up was 35 months (range 1 week to 149 months). Six patients (5%) were converted to open repair during follow-up. Survival was 91% (95% confidence interval, 86% to 96%), 75% (67% to 83%), 55% (44% to 66%), and 41% (28% to 54%) after 1, 12, 60, and 120 months, respectively. Infection-related death occurred in 23 patients (19%), 9 after discontinuation of antibiotic treatment. A Cox regression analysis demonstrated non-Salmonella–positive culture as predictors for late infection–related death. Conclusions—: Endovascular treatment of MAA is feasible and for most patients a durable treatment option. Late infections do occur, are often lethal, and warrant long-term antibiotic treatment and follow-up. Patients with non-Salmonella–positive blood cultures were more likely to die from late infection.

6 December 2016 in Circulation
Verified
Journal Article
Closed access
PDF file
KSKarl Sörelius
Karl Sörelius
AWAnders Wanhainen
Anders Wanhainen
MFMia Furebring
Mia Furebring
MBMartin Björck
Martin Björck
PGPeter Gillgren
Peter Gillgren
MCMing Chu
Ming Chu
Background: No reliable comparative data exist between open repair (OR) and endovascular aneurysm repair (EVAR) for mycotic abdominal aortic aneurysms (MAAAs). This nationwide study assessed outcomes after OR and EVAR for MAAA in a population-based cohort. Methods: All patients treated for MAAAs in Sweden between 1994 and 2014 were identified in the Swedish vascular registry. The primary aim was to assess survival after MAAA with OR and EVAR. Secondary aims were analyses of the rate of recurrent infections and reoperations, and time trends in surgical treatment. Survival was analyzed using Kaplan-Meier and log-rank tests. A propensity score–weighted correction for risk factor differences in the 2 groups was performed, including the operation year to account for differences in treatment and outcomes over time. Results: We identified 132 patients (0.6% of all operated abdominal aortic aneurysms in Sweden). Mean age was 70 years (standard deviation, 9.2), and 50 presented with rupture. Survival at 3 months was 86% (95% confidence interval, 80%–92%), at 1 year 79% (72%–86%), and at 5 years 59% (50%–68%). The preferred operative technique shifted from OR to EVAR after 2001 (proportion EVAR 1994–2000 0%, 2001–2007 58%, 2008–2014 60%). Open repair was performed in 62 patients (47%): aortic resection and extra-anatomic bypass (n=7), in situ reconstruction (n=50), and patch plasty (n=3); 2 patients died intraoperatively. EVAR was performed in 70 patients (53%): standard EVAR (n=55), fenestrated/branched EVAR (n=8), and visceral deviation with stent grafting (n=7); no deaths occurred intraoperatively. Survival at 3 months was lower for OR than for EVAR (74% versus 96%, P <0.001), with a similar trend present at 1 year (73% versus 84%, P =0.054). A propensity score–weighted risk-adjusted analysis confirmed the early better survival associated with EVAR. During median follow-up of 36 and 41 months for OR and EVAR, respectively, there was no difference in long-term survival (5 years 60% versus 58%, P =0.771), infection-related complications (18% versus 24%, P =0.439), or reoperation (21% versus 24%, P =0.650). Conclusion: This study demonstrates a paradigm shift in treatment of MAAA in Sweden, with EVAR being the preferred treatment modality. EVAR was associated with improved short-term survival in comparison with OR, without higher associated incidence of serious infection-related complications or reoperations.

1 January 2010 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
CWCarl Magnus Wahlgren
Carl Magnus Wahlgren
ELEmma Larsson
Emma Larsson
PMPatrik K.E. Magnusson
Patrik K.E. Magnusson
RHRebecka Hultgren
Rebecka Hultgren
JSJesper Swedenborg
Jesper Swedenborg

9 January 2009 in Cerebrovascular Diseases
Verified
Journal Article
Closed access
CWCarl-Magnus Wahlgren
Carl-Magnus Wahlgren
WZWei Zheng
Wei Zheng
WSWael Shaalan
Wael Shaalan
JTJun Tang
Jun Tang
HBHisham S. Bassiouny
Hisham S. Bassiouny
Background: Inflammation is a key mechanism in human atherosclerotic plaque vulnerability and disruption. The objective was to determine the differential gene expression of pro- and anti-inflammatory factors in the fibrous cap and shoulder region of noncalcified and calcified carotid endarterectomy plaques. Methods: Thirty carotid endarterectomy plaques were classified as type Va (noncalcified, n = 15) and type Vb (calcified, n = 15) in accordance with the American Heart Association consensus. Using laser capture microdissection, fibrous cap and shoulder regions were excisedfrom frozen sections. Gene expression of pro- [interleukin 1 (IL-1), IL-8 and monocyte chemoattractant protein 1 (MCP-1)] and anti-inflammatory (IL-10) factors, and bone formation (bone morphogenetic protein 6 and osteocalcin) mediators were quantitated by real-time PCR. Protein levels were determined using Western blotting. Results: Mean percent carotid stenosis and calcification area were 79 and 5% in Va-plaques (40% symptomatic) and 77 and 42% in Vb-plaques (20% symptomatic). Macrophages infiltrating the region of the fibrous cap and the shoulder were more numerous in non-calcified plaques compared with calcified plaques (p < 0.01]. mRNA expression of MCP-1 and IL-8, and protein levels of IL-8 were also greater in Va plaques compared to Vb plaques (p < 0.05). Protein levels and mRNA expression of osteocalcin were greater in Vb compared to Va plaques (p < 0.05). Conclusions: Fibrous cap inflammation is more likely to occur in noncalcified than in calcified plaques. These findings suggest that carotid atherosclerotic plaque calcification is a structural marker of plaque stability.

1 February 2019 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
KSKarl Sörelius
Karl Sörelius
AWAnders Wanhainen
Anders Wanhainen
CWCarl-Magnus Wahlgren
Carl-Magnus Wahlgren
MLMarcus Langenskiöld
Marcus Langenskiöld
HRHåkan Roos
Håkan Roos
KMKevin Mani
Kevin Mani

1 July 2008 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
WSWael E. Shaalan
Wael E. Shaalan
CWCarl M. Wahlgren
Carl M. Wahlgren
TDTina Desai
Tina Desai
GPGiancarlo Piano
Giancarlo Piano
CSChristopher Skelly
Christopher Skelly
HBHisham S. Bassiouny
Hisham S. Bassiouny